Shape the future of specialist commissioning by joining NHS England Specialist Services Clinical Reference Group
Wednesday, 02 October 2013 11:03
NHS England is looking for healthcare scientists to be part of the Clinical Reference Groups (CRGs) that are informing the future organisation and commissioning of Specialist Services in the NHS.
You can help the work of a CRG either through becoming a member of the CRG itself or by signing up as a formal stakeholder of the CRG. We will be also looking to coordinate scientific input for the CRGs through the regional Scientific Directors.
Eight new specialist commissioning policies have just been published by NHS England, including a number pertaining to specialist radiotherapy and radiosurgery.
IBD Registry Launches at BSG 2013 in Glasgow
Wednesday, 10 July 2013 11:22
The IBD Registry was launched at this year's British Society of Gastroenterology Annual Conference in Glasgow.
The mood was positive and delegates very supportive of the work done to develop the Registry and many clinicians in the audience were committed to becoming involved.
One delegate commented that the Registry sounds "amazing", while Dr Anjan Dhar said the project represents "a fantastic effort". Reporting on his experience of piloting the Registry Patient Management System, Dr Matt Johnson commented that "patients love this", and that it "takes ten minutes to learn, and data can be entered in about four minutes by patient 15".
After the event the room was buzzing with enthusiasm and delegates were queuing up to get more information and sign up to get involved.
Redefining How We Use Information
IBD Registry chairman and consultant gastroenterologist Dr Stuart Bloom explained that the Registry – which has been in development for the past two years – provides an opportunity to redefine how we use the clinical information we all generate in routine consultation to improve care for patients as well as providing a tool for service development and research.
Further Information can be found in the full press release below
- Further information [ 26 kb ]
SNOMED Diagnosis Code Update: July 2013
Professor Jonathan L Brown
In the October 2012 eNewsletter the Society was seeking the help of members to assist with the development of a SNOMED subset to allow the diagnosis field of a gastroenterology or hepatology electronic patient record to be populated. The request derived from the DH Informatics Directorate, Connecting for Health (CfH). In March 2013, CfH was superseded by the Health and Social Care Information Centre (HSCIC) and the project continues under their authority.
In the medical subspecialties, paediatrics, renal, rheumatology, respiratory and gastroenterology/hepatology have succeeded in creating a pilot data set and the next objective will be a phase of clinical evaluation. HSCIC is considering technical options for this and it is likely that volunteers will again be required. The BSG pilot data can be viewed below and was derived from the large Swansea database of clinical diagnosis fields combined with the C&B gastroenterology referral library and the Society list of exit examination conditions.
Nikki Simmonds and Jonathan Brown, assisted by a CfH terminologist, merged and contracted the data sets, removed redundancy and validated the SNOMED terms, The scope of the project was to allow a diagnosis field to be populated in 80% of outpatient consultations from a list of about 150 terms and not to produce an exhaustive list of all GI conditions. After evaluation it will become the preferred list of diagnoses for NHS messaging systems and our Society will need to consider a method for maintenance, development and ratification of new terms as clinical gastroenterology and electronic patient records continue to evolve. To this end, the other medical subspecialties have created information committees like the one we have just disbanded and so we will need to devise an alternative strategy if we are to keep up.
- Download BSG pilot data [ 130 kb ]
Golimumab approved for treating some forms of UC
Monday, 20 May 2013 09:58
On 15 May 2013, the U.S. Food and Drug Administration approved a new use for Simponi (golimumab) injection: treatment of adults with moderate to severe ulcerative colitis that is resistant (refractory) to prior treatment or requires continuous steroid therapy. Golimumab had previously been approved to treat rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (arthritis affecting the joints in the spine and the pelvis). The press release provides full details.
Page 4 of 16